日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma

可溶性MAdCAM-1作为转移性肾细胞癌的生物标志物

Alves Costa Silva, Carolina; Machaalani, Marc; Saliby, Renee Maria; Zhong, Caiwei; Xie, Wanling; Pasolli, Edoardo; Piccinno, Gianmarco; Dalban, Cécile; Fidelle, Marine; Meurisse, Aurelia; Vernerey, Dewi; Lee, Gwo-Shu Mary; Birebent, Roxanne; Saad, Eddy; Steiner, Clara; Flippot, Ronan; Barros-Monteiro, Janice; Segata, Nicola; Thiery-Vuillemin, Antoine; Formenti, Silvia; Kuznetsova, Tatiana; Escudier, Bernard; Derosa, Lisa; Zitvogel, Laurence; Choueiri, Toni K; Albiges, Laurence

Publisher Correction: argeting of HIF2-driven cachexia in kidney cancer

出版商更正:针对肾癌中 HIF2 驱动的恶病质的治疗

Abu-Remaileh, Muhannad; Stransky, Laura A; Bhalerao, Nikita; Shirole, Nitin H; Jiang, Qinqin; Saad, Eddy; Machaalani, Marc; Vigeant, Sean M; Woldemichael, Hilina; Xu, Charles; Lu, Jing; Wei, Hairong; Liu, Zhihong; Sun, William; Enomoto, Kei; Choueiri, Toni K; Pitarresi, Jason R; Carr, Steven A; Udeshi, Namrata D; Kaelin, William G Jr

Targeting of HIF2-driven cachexia in kidney cancer.

针对肾癌中由HIF2驱动的恶病质的靶向治疗。

Abu-Remaileh Muhannad, Stransky Laura A, Bhalerao Nikita, Shirole Nitin H, Jiang Qinqin, Saad Eddy, Machaalani Marc, Vigeant Sean M, Woldemichael Hilina, Xu Charles, Lu Jing, Wei Hairong, Liu Zhihong, Sun William, Enomoto Kei, Choueiri Toni K, Pitarresi Jason R, Carr Steven A, Udeshi Namrata D, Kaelin William G Jr

Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2

对伴有 Merlin 蛋白缺乏和 NF2 双等位基因缺失的肾细胞癌进行综合临床和分子评估

Yekedüz, Emre; Bian, Weiwei; Siegmund, Stephanie E; Machaalani, Marc; El Masri, Jad; Saleh, Mustafa; Saad, Eddy; Ascione, Liliana; El Hajj Chehade, Razane; Steiner, Clara; Barrios, Pablo Moura; Berg, Stephanie A; McGregor, Bradley; Mantia, Charlene; Ravi, Praful; Xu, Wenxin; Hirsch, Michelle S; Choueiri, Toni K; Serzan, Michael

AXL signaling in cancer: from molecular insights to targeted therapies

AXL信号通路在癌症中的作用:从分子机制到靶向治疗

Yadav, Monika; Sharma, Akansha; Patne, Ketki; Tabasum, Saba; Suryavanshi, Jyoti; Rawat, Laxminarayan; Machaalani, Marc; Eid, Marc; Singh, Rana P; Choueiri, Toni K; Pal, Soumitro; Sabarwal, Akash

Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma

嗜铬细胞肾细胞癌中肿瘤内在和微环境因素导致抗肿瘤免疫受损

Labaki, Chris; Saad, Eddy; Madsen, Katrine N; Hobeika, Charbel; Bi, Kevin; Alchoueiry, Michel; Camp, Sabrina; Hou, Yue; Bakouny, Ziad; Matar, Sayed; El Ahmar, Nourhan; Nyman, Jackson; Zhang, Long; Priolo, Carmen; Rout, Rishabh; Daou, Melissa; Khabibullin, Damir; Salem, Samer; Schindler, Nicholas; Saliby, Renée Maria; Meli, Kevin; Wells, J Connor; Pimenta, Erica; Takemura, Kosuke; Park, Jihye; Eid, Marc; Semaan, Karl; Fu, Jingxin; Denize, Thomas; El Hajj Chehade, Razane; Machaalani, Marc; Nawfal, Rashad; Khatoun, Wassim Daoud; Saleh, Mustafa; El Masri, Jad; Haddad, Nina Rossa; Xu, Wenxin; McGregor, Bradley A; Hirsch, Michelle S; Xie, Wanling; Heng, Daniel Y C; McDermott, David F; Signoretti, Sabina; Van Allen, Eliezer M; Shukla, Sachet A; Choueiri, Toni K; Henske, Elizabeth P; Braun, David A

The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs

SLC1A1/EAAT3二羧酸氨基酸转运蛋白是一种表观遗传失调的营养载体,它维持着致癌代谢程序。

Treg Grubb ,Pooneh Koochaki ,Sayed Matar ,Fatme Ghandour ,Marc Machaalani ,Eddy Saad ,Cerise Tang ,Eduard Reznik ,Jesminara Khatun ,Carleigh Salem ,Noah Dubasik ,David A Orlando ,Matthew G Guenther ,Gyanu Parajuli ,Raghvendra M Srivastava ,Steven R Martinez ,Jesse A Coker ,Ritesh R Kotecha ,A Ari Hakimi ,John M Asara ,Timothy A Chan ,Sakari Vanharanta ,Shaun R Stauffer ,William G Kaelin Jr ,Sabina Signoretti ,Toni K Choueiri ,Abhishek A Chakraborty

Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders

免疫检查点抑制剂用于已患有自身免疫性神经系统疾病的患者

Fletcher, Kylie; Machaalani, Marc; El Hajj Chehade, Razane; Nassar, Amin H; Nawfal, Rashad; Manos, Michael; Menzies, Alexander M; Aboubakar-Nana, Frank; Hassel, Jessica C; Pinato, David J; Johnson, Alexandra; Olsson-Brown, Anna C; Carlino, Matteo S; Malgeri, Andrea; Cortellini, Alessio; Singh, Aditi; Parikh, Kaushal; Kim, So Yeon; Naqash, Abdul Rafeh; Long, Georgina V; Challa, Pavan; Choueiri, Toni K; Sharon, Elad; Shah, Shailee; Johnson, Douglas B

Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress

靶向AXL可有效克服c-Met诱导的肾癌治疗耐药性,并通过增加氧化应激促进肿瘤细胞死亡。

Akash Sabarwal ,Marc Machaalani ,Laxminarayan Rawat ,Johannes Wedel ,Saba Tabasum ,Yuzuru Sasamoto ,Florian Buerger ,Josie Ascione ,Marc Eid ,Karl Semaan ,Eddy Saad ,Yifan Yang ,Dongwon Lee ,F Stephen Hodi ,Matthew L Freedman ,Gwo-Shu Mary Lee ,Murugabaskar Balan ,Toni K Choueiri ,Soumitro Pal

Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes

晚期透明细胞肾细胞癌中自然杀伤细胞功能进行性障碍及其与临床结局的关系

Xu, W; Birch, G; Meliki, A; Moritz, V; Bharadwaj, M; Schindler, N R; Labaki, C; Saliby, R M; Dinh, K; Horst, J T; Sun, M; Kashima, S; Hugaboom, M; Dighe, A; Machaalani, M; Lee, G-S M; Hurwitz, M; McGregor, B A; Hirsch, M S; Shukla, S A; McDermott, D F; Signoretti, S; Romee, R; Choueiri, T K; Braun, D A